ETHealthworld.com brings latest multiple sclerosis news, views and updates from all top sources for the Indian Health industry.

When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. In October 2024, news broke that Facebook parent company Meta had cracked an "impossible" problem ...

Bluetooth is a technology for short-range data transmission that has become so ubiquitous in recent years that we can no longer imagine life without it. This makes it all the more annoying when ...

Finally, a family friend who worked as a healthcare provider in urgent care took her concerns seriously, ordered tests, and asked if she’d ever had an MRI. Within a month, Chelsea had her first scan ...

Click to share on Facebook (Opens in new window) Facebook Click to share on X (Opens in new window) X The film tells the tale of Sydney Price (Kelly) and Henri Cassell (Wozniczka), who have a ...

Champagne Problems is one of Netflix’s Hallmark-style holiday romances, but with its stellar cast, a hilarious script, and some actually sexy moments between the lead actors, it’s an even better ...

Willowy romantic comedies are a dime-a-dozen at Christmastime, but the only complaints are coming from people who don’t like Christmas rom-coms in the first place. This genre’s fans aren’t looking to ...

Please provide your email address to receive an email when new articles are posted on . The most common comorbidity for both subsets of the study population was obesity. Risk for infection-related ...

Isabella Soares is a Senior Writer for Collider, as well as a Cherry Picks-approved critic. A film and TV enthusiast from an early age, Isabella used to write reviews in her journal growing up, which ...

Aimee Picchi is the associate managing editor for CBS MoneyWatch, where she covers business and personal finance. She previously worked at Bloomberg News and has written for national news outlets ...

Trial tests drug against relapsing form of the disease Drug candidate as effective as Roche's Ocrevus in a separate study Fenebrutinib could bring in over $1 billion in annual peak sales FRANKFURT, ...

Roche has reported wins for its BTK inhibitor fenebrutinib in a pair of phase 3 studies across two multiple sclerosis (MS) populations. One victory was based on the finding that the candidate was ...